Datamonitor's Pharmaceuticals in Singapore industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.

Scope

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and leading companies

* Includes a five-year forecast of the industry

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Market shares are covered by manufacturer and/or brand

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition - The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2005 annual average exchange rates.

Market shares are for sales in 2005, the most recent full year results available.

For the purpose of this report, the European market is deemed to consist of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific consists of Australia, China, India, Japan, Singapore, South Korea and Taiwan.

TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 7
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Competitive Landscape 13
CHAPTER 7 Leading Companies 14
7.1 GlaxoSmithKline Plc 14
7.2 Pfizer Inc 14
7.3 Astellas Pharma 14
CHAPTER 8 Market Forecasts 15
8.1 Market Value Forecast 15
CHAPTER 9 Macroeconomic Indicators 16

CHAPTER 10 Further Reading 18
10.1 Sources 18
10.2 Related Datamonitor Research 18

LIST OF TABLES
Table 1: Singapore Pharmaceuticals Market Value: $ million, 2002-2006 8
Table 2: Singapore Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 9
Table 3: Singapore Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 10
Table 4: Singapore Pharmaceuticals Market Share: % Share, by Value, 2005 11
Table 5: Singapore Pharmaceuticals Market Value Forecast: $ million, 2006-2011 14
Table 6: Singapore Size of Population (million) , 2002-2006 15
Table 7: Singapore GDP (1995=100), 2002-2006 15
Table 8: Singapore Inflation, 2002-2006 15
Table 9: Singapore Exchange Rate, 2002 16